Plasma 24-metabolite Panel Predicts Preclinical Transition to Clinical Stages of Alzheimer’s Disease

We recently documented plasma lipid dysregulation in preclinical late-onset Alzheimer’s disease (LOAD). A 10 plasma lipid panel, predicted phenoconversion and provided 90% sensitivity and 85% specificity in differentiating an at-risk group from those that would remain cognitively intact. Despite the...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Front Neurol
Main Authors: Fiandaca, Massimo S., Zhong, Xiaogang, Cheema, Amrita K., Orquiza, Michael H., Chidambaram, Swathi, Tan, Ming T., Gresenz, Carole Roan, FitzGerald, Kevin T., Nalls, Mike A., Singleton, Andrew B., Mapstone, Mark, Federoff, Howard J.
Formato: Artigo
Idioma:Inglês
Publicado: Frontiers Media S.A. 2015
Assuntos:
Neuroscience
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4642213/
https://ncbi.nlm.nih.gov/pubmed/26617567
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2015.00237
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares